Exposure-Effect Population Model of Inolimomab, a Monoclonal Antibody Administered in First-Line Treatment for Acute Graft-Versus-Host Disease

Author： Dartois Céline   Freyer Gilles   Michallet Mauricette  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.46, Iss.5, 2007-01, pp. : 417-432

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal Antibodies to Treat Graft-Versus-Host Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 6, 2011-06 ,pp. : 473-479

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs for acute graft-versus-host disease

By Khaled Yasser   Reddy Pavan   Krijanovski Oleg  

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 2, 2009-06 ,pp. : 219-232

Informa Healthcare

Access to resources Recommend Favorite

Novel therapeutics for the treatment of graft-versus-host disease

By Jacobsohn David A  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 9, 2002-09 ,pp. : 1271-1280

Informa Healthcare

Access to resources Recommend Favorite

Glucosamine: First report of graft-versus-host disease: case report

By  

Reactions Weekly, Vol. 1, Iss. 1205, 2008-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Progesterone: First report of induction of graft-versus-host disease: case report

By  

Reactions Weekly, Vol. 1, Iss. 1201, 2008-01 ,pp. : 25-25

Adis International

Access to resources Recommend Favorite